Funding Opportunity RFA-AI-21-035 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support exploratory research focused on developing innovative methods and algorithms in biomedical computing, informatics, and data science addressing priority needs across the infectious diseases, emerging infections, or immune-mediated diseases (that include allergy, autoimmunity, or immune reactions associated with transplantation henceforth referred to as "infectious or immune-mediated diseases") research continuum and align with the research mission of NIAID. As a part of the trans-NIAID Data Science (AI-DS) program, this R21 FOA encourages applications focused on the development of novel computational, mathematical, and statistical algorithms and methods, including artificial intelligence and machine learning approaches, that can considerably improve acquisition, management, analysis, and dissemination of relevant data and/or knowledge.

Funding Opportunity RFA-AI-21-021 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications for the enhancement and/or sustainment of high-value data science research software to improve the acquisition, management, analysis, visualization, and dissemination of data and knowledge across the immune-mediated, and infectious-disease research continuum, aligned with the research mission of NIAID. This includes infectious diseases, emerging infections, or immune-mediated diseases that include allergy, autoimmunity, or immune reactions associated with transplantation. As a part of the trans-NIAID data science program, this FOA focuses on enhancement and/or sustaining operations and improving the user experience and availability of existing, widely adopted informatics tools and resources. This contrasts with exploratory (R21) and early-stage (U01) development efforts to generate these tools and resources that are supported by the companion FOA s.

Funding Opportunity RFA-AI-21-020 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications for the development of enabling data science technologies to improve the acquisition, management, analysis, visualization, and dissemination of data and knowledge for immune-mediated and infectious diseases including disease mechanism, risk prediction, epidemiology, detection and diagnosis, treatment and vaccines across the allergy, immune-mediated, and infectious-disease research continuum, aligned with the research mission of NIAID. This includes infectious diseases, emerging infections, or immune-mediated diseases that include allergy, autoimmunity, or immune reactions associated with transplantation. As a part of the trans-NIAID data science program, this FOA focuses on early-stage development from prototyping to hardening and adaptation. Early-stage development is defined for the purpose of this FOA as initial tool development or the significant modification of existing tools for new applications. This contrasts with exploratory (R21) and enhancement/sustainment (U24) efforts to generate these tools and resources that are supported by the companion FOA s.

Negotiable: Paramount Recruitment: Cancer Genomics Data Scientist London Genomics Data Scientists investigate and develop solutions to extract more information from the genome (ali London, England

Funding Opportunity RFA-DK-21-004 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages applications from institutions and organizations proposing original research aimed at the characterization of the function of neoepitopes and neoantigens in type 1 diabetes. This includes the function that post-translational modifications might have in the humoral and cell mediated autoimmune responses and overall in the etiology and pathophysiology of type 1 diabetes. Proposals that include the discovery of neoantigens or neoepitopes are within the scope of this solicitation, but should propose a plan for integrating these discoveries with the present knowledge on established epitopes and antigens (e.g. autoantibodies for insulin, GAD65, IA-2, and ZnT8). In the long-term the goals of this initiative are to facilitate the development of better tools to monitor disease progression and treatment, and potentially to facilitate the development of personalized therapeutics.

Funding Opportunity PAR-21-167 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) encourages innovative research to develop, characterize, and improve animal models, biological materials, and novel technologies to better understand human health and disease. This FOA also seeks projects aimed at improving the diagnosis and control of diseases that interfere with animal use for biomedical research. The proposed project must have broad application to multiple NIH Institutes or Centers (ICs) to align with the Office of Research Infrastructure Programs (ORIP) trans-NIH mission. The proposed studies must explore multiple body systems or evaluate diseases that impact multiple body systems. Applications that develop models focused on a specific disease or area of research, or only propose studies primarily relevant to a single NIH IC will be considered not acceptable to this FOA.

Notice NOT-NS-21-029 from the NIH Guide for Grants and Contracts

Plus Benefits: Paramount Recruitment: Principal Scientist, Patient Data Analytics. - Berkshire! I am currently working with a global bio-pharmaceutical company focused on creating va Maidenhead, England

Competitive Salary: EMBL: About this position We are looking for two Legal Officers to join us at the European Molecular Biology Laboratory – European Bioinformatics Institu Hinxton, Cambridgeshire, England

Competitive Salary: EMBL: About this position The Ensembl Applications team is looking for a talented software developer to create innovative web services as part of the Ens Hinxton, Cambridgeshire, England

Competitive Salary: EMBL: About this position We are seeking an experienced software developer to join the InterPro team at the European Bioinformatics Institute (EMBL-EBI) Hinxton, Cambridgeshire, England

PhD in Computer Science, Biomedical Engineering, Bioinformatics, or related field. The University of Wisconsin-Madison fulfills its public mission by creating a…
From University of Wisconsin–Madison - Wed, 17 Mar 2021 00:57:35 GMT - View all Madison, WI jobs

A number of Bock investigators are involved in teaching or development of bioinformatics software and they utilize a variety of platforms (Mac, PC, Linux, Unix)…
From University of Wisconsin–Madison - Tue, 16 Mar 2021 18:57:33 GMT - View all Madison, WI jobs

Notice NOT-NS-21-042 from the NIH Guide for Grants and Contracts

Notice NOT-HL-21-005 from the NIH Guide for Grants and Contracts

Notice NOT-HL-21-004 from the NIH Guide for Grants and Contracts

Notice NOT-CA-21-041 from the NIH Guide for Grants and Contracts

Notice NOT-NS-21-040 from the NIH Guide for Grants and Contracts

Notice NOT-NS-21-038 from the NIH Guide for Grants and Contracts

Negotiable: Paramount Recruitment: Immuno-oncology Bioinformatics Scientist - Berkshire! I am currently working with a global bio-pharmaceutical company focused on creating value fo Maidenhead, England